OTAKU: OrthoEvidence Trial Assessing Japanese Knowledge Updates

Sponsor
McMaster University (Other)
Overall Status
Completed
CT.gov ID
NCT05250622
Collaborator
Japanese Society for Fracture Repair (Other), OrthoEvidence (Other)
105
1
2
3.7
28.5

Study Details

Study Description

Brief Summary

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

Condition or Disease Intervention/Treatment Phase
  • Other: Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
  • Other: English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
N/A

Detailed Description

The investigators will conduct the survey regarding baseline characteristics, barriers and familiality to evidence-based medicine by online. After the survey, the participants will be randomly assigned to receive either the original version of ACE reports or Japanese version of ACE reports. The pdf of each ACE report will be provided to the participants through an email link. Twenty reports will be sent over 4 weeks period. After that, the investigators will conduct another survey regarding the reports.

Study Design

Study Type:
Interventional
Actual Enrollment :
105 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
OrthoEvidence Trial Assessing Japanese Knowledge Updates : Trial of Knowledge Translation Among Japanese Surgeons
Actual Study Start Date :
Apr 8, 2022
Actual Primary Completion Date :
Jul 1, 2022
Actual Study Completion Date :
Jul 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Japanese group

Participants who will receive Japanese-translated version of evidence summaries

Other: Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Participants will receive emails with the link to Japanese-translated version of evidence summaries.

Active Comparator: English group

Participants who will receive English version of evidence summaries

Other: English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Participants will receive emails with the link to English version of evidence summaries.

Outcome Measures

Primary Outcome Measures

  1. Number of access to evidence summaries [Four weeks (28 days) after the commencement of the trial]

    Total number of access to evidence summaries

Secondary Outcome Measures

  1. Self-rated score of understanding the contents of the provided materials [Within four weeks after the end of intervention]

    Five-point Likert scale in understanding the contents of provided materials, evaluated by the participants (higher scores means better outcome)

  2. Self-rated score in changing their practice based on the contents of the materials [Within four weeks after the end of intervention]

    Five-point Likert scale in changing their practice based on the contents of the materials evaluated by the participants (higher scores means better outcome)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Member of Japanese Society for Fracture Repair (JSFR)

  2. Spend at least 20% of their time in clinical practice

  3. Non-native speaker of English

  4. Has regular access to internet

  5. Prefer to read Japanese-translated material, if there are both translated and English version of the same material.

Exclusion Criteria:

We will exclude surgeons who cannot provide informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 McMaster University Hamilton Ontario Canada L8S 4E8

Sponsors and Collaborators

  • McMaster University
  • Japanese Society for Fracture Repair
  • OrthoEvidence

Investigators

  • Principal Investigator: Kim Madden, PhD, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
McMaster University
ClinicalTrials.gov Identifier:
NCT05250622
Other Study ID Numbers:
  • 13493
First Posted:
Feb 22, 2022
Last Update Posted:
Aug 2, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by McMaster University

Study Results

No Results Posted as of Aug 2, 2022